Physician profile
Steven Gorin
NPI 1750315875
$27,128.21
in general payments reported to CMS, 2019-2025
44 companies · $1,937 in 2025
The $1,937 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,170 · 2020: $2,633 · 2021: $2,581 · 2022: $1,651 · 2023: $5,186 · 2024: $9,969 · 2025: $1,937.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $9,239 · Food and Beverage: $5,004 · Consulting Fee: $2,850.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $9,238.57 |
| Food and Beverage | $5,004.08 |
| Consulting Fee | $2,850.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $7,246.53 | 2022-2025 | Biobrace 23mm |
| Southern Edge Orthopaedics, INC. | $4,140.90 | 2019-2023 | |
| Smith+Nephew, INC. | $3,810.29 | 2019-2025 | Q-Fix, Spatial Frame, Healicoil |
| Arthrex, INC. | $3,335.05 | 2020-2025 | |
| Medacta USA, INC. | $1,303.30 | 2021-2024 | Mecta |
| Stryker Corporation | $1,098.02 | 2020-2025 | Inspace, Tornier Perform Reversed Augmented Glenoid, Blueprint Patient Specific Instrumentation |
| Bioventus LLC | $962.55 | 2021-2025 | Exogen Ultrasound Bone Healing System, Durolane |
| Miach Orthopaedics, INC. | $688.30 | 2022-2025 | |
| Pacira Pharmaceuticals Incorporated | $658.70 | 2023-2025 | Iovera |
| Horizon Therapeutics Plc | $584.57 | 2019-2023 | Krystexxa |
| Biotissue Holdings INC. | $345.77 | 2024-2025 | |
| Depuy Synthes Sales INC. | $310.34 | 2019-2025 | Orthovisc, Monovisc |
| Pacira Therapeutics, INC. | $226.93 | 2019-2021 | |
| Innovation Technologies INC | $199.00 | 2019 | |
| Orthofix Medical, INC. | $177.13 | 2019-2023 | Physio-Stim |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $172.95 | 2023 | Proclaim |
| Wright Medical Technology, INC. | $158.45 | 2019 | |
| Biorez, INC. | $156.05 | 2022 | |
| Shoulder Innovations, INC. | $154.25 | 2024 | Inset System |
| Zimmer Biomet Holdings, INC. | $134.57 | 2021-2025 | Tapestry, Comprehensive Shoulder System |
| Ibsa Pharma INC. | $131.33 | 2021-2024 | Tirosint, Licart |
| Djo, LLC | $125.96 | 2020-2025 | Cmf |
| Catalyst Orthoscience | $112.88 | 2024 | Catalyst Csr Shoulder System |
| Medical Device Business Services, INC. | $112.12 | 2019 | |
| Embody, INC. | $90.93 | 2021 | |
| Anika Therapeutics, INC. | $75.14 | 2019 | |
| Vericel Corporation | $64.25 | 2021-2024 | Maci |
| Integra Lifesciences Corporation | $58.69 | 2019-2022 | |
| Ermi LLC | $57.14 | 2020 | |
| Electronic Waveform Lab, INC. | $56.83 | 2024 | |
| Kerecis Limited | $51.33 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Amgen INC. | $46.51 | 2021-2024 | Krystexxa |
| Heron Therapeutics, INC. | $39.63 | 2024 | Zynrelef |
| Ossdsign USA Incorporated | $37.50 | 2024 | |
| Amniox Medical, INC. | $26.57 | 2020 | |
| Heraeus Medical, LLC. | $24.99 | 2024 | |
| Nalu Medical, INC. | $22.61 | 2024 | Nalu Neurostimulation System |
| Vertex Pharmaceuticals Incorporated | $21.83 | 2025 | |
| Solventum Corporation | $20.98 | 2024 | Prevena, V.A.C. Veraflo Cleanse Choice |
| Stimwave Technologies Incorporated | $20.14 | 2022 | |
| Curonix LLC | $19.00 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Sonex Health, INC. | $17.34 | 2020 | |
| Kci USA, INC. | $15.64 | 2022 | |
| Organogenesis INC. | $15.22 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Gorin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.